RECALL RECORD — CLASS IIIRecall closedF-1762-2013/FDA enforcement
El Campestre·Food·Jun 13, 2013

Brand Ceviche De Basa

What you need to know

Class III
  • What happened

    El Campestre initiated this recall due to the following reason: mislabeling: does not contain Basa fish, it contains Swai fish.

  • Health risk

    The product is unlikely to cause adverse health consequences. These recalls are often related to labeling or quality violations. Fish-derived ingredients were omitted from the label, creating a risk for fish-allergic consumers.

  • Action required

    Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction.

Recall closed · classified by the FDACAMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameEl Campestre
Recalling firmEl CampestreCompton, CA, United States
UPC / barcodesNo UPC listed in the FDA enforcement record.
Lot / date codes
  • Product is not coded with lot numbers. Expiration date 06/01/13
Distribution area
CA

CA

United States

Quantity affected259
Recall initiationFDA report date: August 7, 2013
FDA recall numberF-1762-2013

Beyond the headline

The recall, in context

El Campestre initiated this food recall on June 13, 2013. The FDA enforcement report states: El Campestre initiated this recall due to the following reason: mislabeling: does not contain Basa fish, it contains Swai fish. The FDA report lists distribution as: CA.

The FDA enforcement report describes the reason as: El Campestre initiated this recall due to the following reason: mislabeling: does not contain Basa fish, it contains Swai fish.

Brand Ceviche De Basa was made or distributed by El Campestre in Compton, CA, United States. This page reflects FDA report F-1762-2013, dated August 7, 2013.

Why this is a Class III recall

Class III means the product is unlikely to cause adverse health consequences. These recalls are often related to labeling or quality violations. In this recall, an allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

FDA definition

The product is unlikely to cause adverse health consequences. These recalls are often related to labeling or quality violations.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the lot and date codes against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Undeclared fish

Symptoms to watch for

Hives, swelling, wheezing, vomiting or anaphylaxis can occur in people with a fish allergy.

When symptoms may appear

Reactions can begin within minutes to a few hours after eating the product.

Higher-risk groups

People with a diagnosed fish allergy, especially anyone with a history of anaphylaxis.

What to do now

  1. 1Do not eat the product if you have a fish allergy.
  2. 2Seek emergency care for breathing difficulty, throat swelling or other signs of anaphylaxis.
  3. 3Keep the packaging and contact the retailer or manufacturer about a refund.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Brand Ceviche De Basa recall?

El Campestre recalled Brand Ceviche De Basa in an FDA Class III enforcement action reported as F-1762-2013. El Campestre initiated this recall due to the following reason: mislabeling: does not contain Basa fish, it contains Swai fish.

What are the symptoms of Undeclared fish exposure?

Hives, swelling, wheezing, vomiting or anaphylaxis can occur in people with a fish allergy.

How quickly can Undeclared fish symptoms appear?

Reactions can begin within minutes to a few hours after eating the product.

Who is most at risk from Undeclared fish?

People with a diagnosed fish allergy, especially anyone with a history of anaphylaxis.

What should I do if I bought this product?

Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction. Do not eat the product if you have a fish allergy. Seek emergency care for breathing difficulty, throat swelling or other signs of anaphylaxis. Keep the packaging and contact the retailer or manufacturer about a refund.

How do I get a refund from El Campestre?

Contact the recalling company or the retailer where you purchased the product, quote the FDA recall number and ask about a refund or replacement. Keep the packaging, lot code and proof of purchase where possible. The FDA does not issue consumer refunds. Reference FDA recall F-1762-2013 and keep the packaging, lot code and proof of purchase if you have them.

Is the El Campestre recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-1762-2013. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by El Campestre

View brand

Related alerts

Recent Undeclared fish recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.